Parliamentary Standing Committee
June 14, 2017
Welcomes
NATIONAL INSTITUTE OF
PHARMACEUTICAL EDUCATION AND RESEARCH
(NIPER) S.A.S. NAGAR
Vision of NIPER, S.A.S. Nagar
2
Formed as a society on Feb. 15, 1991,
under the aegis of
the Ministry of Chemicals and Fertilizers
Establishment of NIPER, S.A.S. Nagar
[Govt. of India Gazette Notification, 26.06.1998]
3
Historical Perspective
4
1991 Registered as a Society
1994 First Director and core faculty
joined
1996 Initiation of research activities
1998 Declared “Institute of
National Importance.”
Admission of first batch of
Masters‟ students
2000 Dedication of NIPER to the
Nation
2001 Visit of Joint Parliamentary
Committee
First Convocation
2003 Second Convocation:
Dr. A.P.J. Abdul Kalam,
Visitor and Chief Guest
2004 Establishment of National
Bioavailability Centre
2005 Establishment of National
Toxicology Centre
2007 Amendment of NIPER Act to
establish Six New NIPERs
2009 Establishment of Small and
Medium Pharmaceutical
Industry Centre
2016 „Silver Jubilee „ Year
5
Governance at NIPER, S.A.S. Nagar
BOARD OF GOVERNORS Chairman: Eminent academician/scientist/
technologist/professional, to be
nominated by the Visitor
SENATE Chairman: Director, NIPER, S.A.S. Nagar
ACADEMIC PLANNING
AND DEVELOPMENT
COMMITTEE
Chairman: Eminent academician/scientist/
technologist, to be nominated by the BoG
FINANCE COMMITTEE Chairman: Director, NIPER, S.A.S. Nagar
LABORATORY SERVICES,
BUILDING AND WORKS
COMMITTEE
Chairman: Director, NIPER, S.A.S. Nagar
BOARD OF STUDIES AND
RESEARCH
Chairman: Dean, NIPER, S.A.S. Nagar
6
BoG Director
Dean
• Academic Administration
• Examination
HoDs
• Academic Departments
Registrar
• Finance & Accounts
• Administration
• Purchase
• Maintenance
Administration at NIPER, S.A.S. Nagar
• Teaching activities
• Research activities
• Interaction with industry
Mandate, NIPER, S.A.S. Nagar
8
HUMAN
RESOURCE
DEVELOPMENT
R&D
ACTIVITIES
Activities at NIPER, S.A.S. Nagar
Societal needs
Translational
Research
Industrial Support
Academics: Interdisciplinary Courses Medicinal Chemistry
Pharmaceutics
Natural Products
Traditional Medicine
Pharmacology & Toxicology
Regulatory Toxicology
Pharmaceutical Analysis
Biotechnology
Pharmaceutical Technology (Formulations)
Pharmaceutical Technology (Process Chemistry)
Pharmaceutical Technology (Biotechnology)
Pharmacy Practice
Clinical Research
Pharmacoinformatics
Pharmaceutical Management
Degrees Offered
• M. S. (Pharm.)
• M. Pharm.
• M. Tech. (Pharm.)
• M. B. A. (Pharm.)
• Ph. D.
DIS
CIP
LIN
ES
9
10 10
Formulation Development
Approval & Marketing
Drug Discovery
Clinical Testing
(Phase I)
MEDICINAL CHEMISTRY
NATURAL PRODUCTS
BIOTECHNOLOGY
PHARMACOINFORMATICS
PHARMACOLOGY & TOXICOLOGY
PHARMACEUTICAL ANALYSIS
PHARMACOINFORMATICS
PHARMACEUTICAL TECHNOLOGY
PHARMACEUTICS
BIOTECHNOLOGY
PHARM. MANAGEMENT
PHARMACY PRACTICE
Pre-clinical Development
GREEN: STAGES OF DRUG DISCOVERY
BLACK: DEPARTMENTS
Academics: Drug discovery to market
NIPER
INDUSTRY
Earlier trend: R&D efforts in the pharma industry were taken care of by degree
holders in basic sciences
Current trend: With the graduates from NIPER, S.A.S. Nagar, R&D activities
are strengthened by trained manpower skilled in the nuances of
pharmaceutical sciences
Orientation of Academic
Programme at NIPER
All Masters‟ and Ph.D. degrees at NIPER, S.A.S. Nagar, are research-based
11
KNOWLEDGE
THRUST AREAS:
Neglected diseases
OTHER AREAS
Leishmaniasis (Kala Azar)
Tuberculosis
Formulation Development
Impurity Profiling
Pharmaceutical
Nanotechnology
Biopharmaceuticals
Proteomics
Functional Genomics
Pharmacoinformatics
Drug Discovery Drug Development
Malaria
Diabetes and other
lifestyle diseases
Research Areas
12
Year PhD
2002 5
2003 17
2004 6
2005 16
2006 7
2007 5
2008 13
2009 11
2010 6
2011 29
2012 17
2013 26
2014 27
2015 25
2016-17** 50
TOTAL 260
Batch Masters’ MBA (Pharm.)
Dec 1999 27 -
Dec 2000 35 -
Dec 2001 37 -
Dec 2002 43 -
Dec 2003 55 -
July 2004* - 28
July 2005 67 29
July 2006 85 28
July 2007 87 19
July 2008 89 30
July 2009 99 34
July 2010 126 37
July 2011 147 43
July 2012 230 58
July 2013 232 52
July 2014 257 64
July 2015 167 28
July 2016 177 37
TOTAL 1960 487
HRD at NIPER, S.A.S. Nagar
* Semester system changed from 3 to 4. ** Till date
13
Output at NIPER, S.A.S. Nagar
Placement of graduating students is distributed over
• Academia (Doctoral and Postdoctoral positions)
• Academia (Teaching positions)
• Pharmaceutical industry (National)
• Pharmaceutical industry (International)
• Regulatory bodies (National & International)
14
Hospital
Pharmacy
Regulatory
Affairs Entrepreneurship
Medico-
Journalism
Quality
Control
Production
Career
Opportunities
Research &
Development Sales &
Marketing
Academics
15
16
Some of our Recruiters
(Academic and Regulatory Agencies)
Our graduating students have been admitted to many top-
ranked institutes as PhD candidates, Post-doctoral Fellows
and as Faculty members
• IITs, IISERs, IISc
• TIFR, NCBS
• CSIR labs
• Universities in India
• Universities / Institutes in USA, Europe, Australia, New Zealand
Regulatory Agencies
• CDSCO
• USFDA
Some of our recruiters (Industry)
Output at NIPER, S.A.S. Nagar
Publications
Highest
impact
factor
Patents
filed
Patents
granted
Patents
licensed
>2,100 40 182* 48* 07**
• Data till June 2017
• Includes some patents at different stages of filing and those granted to other
agencies as assignees
* Including foreign filings / approvals
** Including one patent which has been licensed to two US - based companies.
18
Zinc Dispersible Tablets
NanoCrySP is a novel Spray
Drying Based method to
generate solid particles
containing drug nanocrystals
and small molecule excipients
Licensed to M/s Windlas Biotech Ltd.
Technology licensed out
20
Technology licensed out
21
Current Membership of SMPIC: 110
Skill development at SMPIC
22
Amendment of NIPER Act
23
Impact of NIPER, S.A.S. Nagar
S.A.S. Nagar
Raebareli
Hajipur
Kolkata
Guwahati
Hyderabad
Ahmedabad
24
MHRD NIRF 2017 Rankings
(Category: Pharmacy)
Where do we stand vis-a-vis
other institutes?
NIPER S.A.S. Nagar achieved the second rank
26
Where do we stand vis-a-vis
other institutes? Degree
awarding
institute
Output
(100)
Impact
(100)
IP
(125)
Learning
(175)
Productivity
(50)
Total
(550)
AAAAA
IISc,
Bangalore
100.0 30.1 120.0 159.0 42.0 451.1
AAAA+
JNCASR,
Bangalore
24.0 46.1 79.0 150.0 50.0 349.1
TIFR,
Mumbai
47.3 59.5 71.0 146.0 18.1 341.9
NIPER,
Mohali
6.1 42.8 99.0 145.0 19.0 311.8
ICT,
Mumbai
19.4 26.6 71.5 145.0 45.0 307.4
[Data from Careers360 magazine, March 2014 issue]
27
Where do we stand vis-a-vis
other institutes?
Degree awarding
institute
Year of
establishment
AAAAA
IISc, Bangalore 1909
AAAA+
JNCASR, Bangalore 1989
TIFR, Mumbai 1945
NIPER, Mohali 1994
ICT, Mumbai 1933
28
Where do we stand vis-a-vis
other institutes?
[Times of India, Chandigarh edition]
[09.03.2015]
Where do we stand vis-a-vis
other institutes?
NIPER, S.A.S. Nagar was awarded Thomson Reuters Innovation Award 2011 based
on
• The number of basic inventions published in the previous year
• The ratio of granted patents to basic inventions
• The global reach of the portfolio
• The overall influence of the portfolio as determined by international citations of
its research 29
Other recognitions Shanti Swaroop Bhatnagar Award
Ranbaxy Research Award
National Bioscience Award
JC Bose Fellowship
DBT Young Women Scientist Award
INSA Young Scientist Award
Distinguished Educator and Researcher Award (AAiPS)
IBM Faculty Award
OPPI Award
Chemical Research Society of India medal
Shakuntala Amir Chand Prize (ICMR)
Punjab Ratan Award
Advisor, WHO expert committee on specifications for pharmaceutical
preparations
Member, WHO Expert advisory panel on the International
Pharmacopoeia and Pharmaceutical Preparations
Innocentive Award
and others ...
Members, Fellows, National and International Science Academies 30
31
Promotion and coordination of basic
and applied research in areas related
to pharmaceutical sectors
The economics of drug discovery process
prevents many small-scale entrepreneurs from
participation.
Provision of a platform containing common facilities to
scientists where the entire chain of drug discovery and
development process can be carried out without the
need for initial investment of capital budget.
32
Promotion and coordination of basic
and applied research in areas related
to pharmaceutical sectors Solution to ‘Phase II’ attrition problem.
Establishment of R&D hub in the drug discovery and development
programme
Provision of soft loans to pharmaceutical industries to carry out R&D
activities with support of NIPER S.A.S. Nagar or to provide funds for
collaborative research between academia and industry
Industry should become a part of the R&D process right in the
beginning
Industry supported fellowship programmes as well as research
programmes of mutual interest
Inclusive participation of alumni in growth of Institute
Financial support from the DoP to set up an incubator research
facility for the pharmaceutical industry
33
Gross receipts (Rs. in lakh)
Year Sponsored
Projectsa
Sponsored
Consultancyb
2012-13 426.01 79.65
2013-14 247.95 94.77
2014-15 261.78 125.60
2015-16 336.23 134.94
2016-17 207.89 107.09
Working with external agencies
a From extramural funding agencies and industry b From industry
34
Working with the industry
Company Project details
Alliance Formulations 3rd Generation synergistic
disinfectant
Cachet Pharma Anti snoring formulation
DSM Sinochem Amoxicillin and Clavulanic acid
tablets
Alliance Formulation Algard disinfectant formulation
DSM Sinochem Amoxicillin and Clavulanic acid
dry suspension
Promed (Sentiss) Ophthalmic formulation
AP Organics Oryznol capsule formulation
NIPER S.A.S. Nagar has carried out laboratory scale development of a
few formulations whether on their own or as sponsored projects from the
industry. Subsequently, the formulations were scaled up and
commercialized by the pharmaceutical industry. A few illustrative
instances are provided below:
Challenges being faced
• Shortage of faculty: Maintenance of optimal faculty-student
ratio.
• Release of funds under XII Plan approved by SFC.
- Approved: Rs. 249.455 cr
- Released: Rs. 9.79 cr only
• Urgent requirements:
(a) Replacement of old research equipment
(b) Creation of infrastructure like lecture halls, laboratories, etc.
(c) Maintenance of campus
• Short of Non-Plan funds every year
• Non-recognition of M.S. (Pharm.) degree by UGC has put
the career of many students at stake.
35
36
Emphasis in near future
Digital India
• E-Governance
• E-Tendering
• Electronic eye
Make in India
• Skill development and Startups
37
NIPER, SAS Nagar
is well equipped to meet
all the expectations of the country in
the field of Pharmaceutical Sciences
and Technology
We seek your
blessings and support
Thank you! 38